CDNA
CDNA
NASDAQ · Biotechnology

Caredx Inc

$21.82
+0.38 (+1.77%)
As of May 10, 10:12 PM ET ·
Financial Highlights (FY 2026)
Revenue
364.15M
Net Income
-20,472,001
Gross Margin
67.5%
Profit Margin
-5.6%
Rev Growth
+5.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.5% 67.5% 39.5% 39.5%
Operating Margin -8.1% -7.3% -17.7% -19.5%
Profit Margin -5.6% -5.3% -18.5% -18.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 364.15M 344.58M 329.37M 271.09M
Gross Profit 245.98M 232.76M 130.20M 107.16M
Operating Income -29,496,005 -25,119,610 -58,208,720 -52,994,442
Net Income -20,472,001 -17,434,520 -60,795,749 -51,228,951
Gross Margin 67.5% 67.5% 39.5% 39.5%
Operating Margin -8.1% -7.3% -17.7% -19.5%
Profit Margin -5.6% -5.3% -18.5% -18.9%
Rev Growth +5.7% +5.7% -9.3% +22.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 344.44M 346.18M
Total Equity 455.35M 445.81M
D/E Ratio 0.76 0.78
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -26,516,018 -23,836,314 -79,903,104 -63,531,119
Free Cash Flow -60,969,564 -57,293,986